BioCentury
ARTICLE | Company News

Signal Pharmaceuticals, University of Massachusetts Medical School deal

October 5, 1998 7:00 AM UTC

Signal received exclusive rights to the school's U.S. Patent No. 5,736,381 covering MKK6 and MKK7, two proteins involved in modulating the p38 and JNK gene regulation pathways, and JIP-1, a JNK regul...